2-((tert-Butoxycarbonyl)amino)-6-methylbenzoic acid, 1g

Ethyl 4-hydroxy-3,5-diiodobenzoate, 97%, 5g

(4aR,5R,6S)-4a-Hydroxy-6-(((2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)-5-vinyl-4,4a,5,6-tetrahydropyrano[3,4-c]pyran-1(3H)-one, 97%, 100mg

GC capillary column ROTI®Cap-1701, 60 m, 0.25 mm, 0.25 µm, 1 Piece(s)

4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-2-(trifluoromethyl)benzoic acid, 95%, 1g

Palladium wire 99.9% 0.3 mm diameter 1 m

2-Chloro-3-methylisonicotinonitrile, 95.0%, 5g

3-Chloro-5-(trifluoromethyl)pyridine-2-carboxylate acid, 97.0%, 100g

Methyl 4-hydroxypiperidine-2-carboxylate hydrochloride, 97%, 10g

3-Formylphenoxyacetic acid, 97%, 5g

[3-(4-methylphenyl)oxetan-3-yl]methanol, 95.0%, 1g

1,2,3,4,5,6,7,8-Octahydronaphthalene, 98%, 1g

1H-Imidazole, 2-[[4-(1,1-dimethylethyl)-2,6-dimethylphenyl]methyl]-4,5-dihydro-, hydrochloride (1:1), 98%, 1g